• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC DUROLANE; HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC DUROLANE; HYALURONIC ACID Back to Search Results
Model Number N/A
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Code Rash (2033)
Type of Reportable Event Serious Injury
Event or Problem Description
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.
 
Event or Problem Description
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.
 
Additional Manufacturer Narrative
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.A request for additional information including the patient's medical history, allergies, relevant medications, prior injections, indication for durolane, patient status, medical interventions or treatments, and injection technique from the prescribing healthcare provider has been initiated for investigation and medical assessment of the event.
 
Additional Manufacturer Narrative
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.A request for additional information including the patient's medical history, allergies, relevant medications, prior injections, indication for durolane, patient status, medical interventions or treatments, and injection technique from the prescribing healthcare provider has been initiated for investigation and medical assessment of the event.\ \ no additional information has been received for the investigation.\ \ the medical assessment of the reported rash is not impetigo, a highly contagious bacterial skin infection which may or may not manifest with blisters.Although the clinical information is very limited (including, but not limited to, the lack of a biopsy results, if one was performed), the clinical appearance of the cutaneous lesion is consistent with ischemic skin necrosis consistent with nicolau syndrome, a rare complication of hyaluronic acid injections.While nicolau syndrome remains a plausible explanation for the observed findings, the atypical anatomical distribution and limited supporting clinical information preclude a definitive diagnosis.In this case, the event of presumed nicolau syndrome following durolane injection is reasonably concluded to have been caused or may have been caused or contributed to by the device (durolane).\ \ although intraarticular visco supplementation is intended to be injected into the joint space, not in any soft tissue structure, inadvertent direct injury to and/or injection of material into the underlying skin vessels has been known to occur with visco supplementation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE
Common Device Name
HYALURONIC ACID
Manufacturer (Section D)
BIOVENTUS LLC
4721 emperor blvd, suite 100
durham NC 27703
Manufacturer (Section G)
Q-MED AB
seminariegatan 21
uppsala, swe SWE-7 52 2
SW   SWE-752 28
Manufacturer Contact
william heard
4721 emperor blvd, suite 100
durham, NC 27703
+1(800)396-4325
MDR Report Key50737169
Report Number3009595577-2026-00003
Device Sequence Number16314694
Product Code MOZ
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P170007/S014
Number of Events Summarized1
Summary Report (Y/N)Y
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician Assistant
Type of Report Initial,Followup
Report Date (Section B) 10/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number1082020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/12/2026
Supplement Date Received by Manufacturer08/12/2026
Initial Report FDA Received Date09/11/2026
Supplement Report FDA Received Date10/14/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Disability;
Patient SexUnknown
-
-